Our members have led paradigm-changing clinical trials that have transformed care for thyroid cancer patients. These efforts have already contributed to the FDA approval of two new therapies for medullary thyroid cancer and introduced innovative new approaches for treating differentiated thyroid cancer. We are doctors, scientists, and patients whose lives and careers are dedicated to discovering and advancing new therapies.
Today, ITOG is building on this foundation of success by forging collaborative efforts that accelerate drug discovery, clinical trial design, and scientific innovation.
These advances require collective effort and your partnership matters. You can help us catalyze a cure by making a financial contribution to ITOG, a 501(c)(3) tax-exempt public charity. Your gift directly supports groundbreaking research and may be tax-deductible.
Explore our interactive map to see where ITOG members are located. Our multidisciplinary community spans institutions, specialties, and countries worldwide.
